000			01997 a2200529 4500
005			20250512104301.0
264		0	_c19710810
008			197108s 0 0 eng d
022			_a0002-9149
024	7		_a10.1016/0002-9149(71)90232-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aHampton, J
245	0	0	_aTrends in the development of antithrombotic agents. _h[electronic resource]
260			_bThe American journal of cardiology _cJun 1971
300			_a659-69 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdenine Nucleotides _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents _xtherapeutic use
650	0	4	_aAnticholesteremic Agents _xtherapeutic use
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aAspirin _xtherapeutic use
650	0	4	_aBlood Platelets _xdrug effects
650	0	4	_aButyrates _xtherapeutic use
650	0	4	_aDextrans _xtherapeutic use
650	0	4	_aDietary Fats
650	0	4	_aDipyridamole _xtherapeutic use
650	0	4	_aEthylestrenol _xtherapeutic use
650	0	4	_aFibrin _xmetabolism
650	0	4	_aFibrinolytic Agents _xtherapeutic use
650	0	4	_aHistamine H1 Antagonists _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aPhenformin _xtherapeutic use
650	0	4	_aPhenylbutazone _xtherapeutic use
650	0	4	_aPlatelet Adhesiveness _xdrug effects
650	0	4	_aPovidone _xtherapeutic use
650	0	4	_aProstaglandins _xtherapeutic use
650	0	4	_aPulmonary Embolism _xprevention & control
650	0	4	_aRabbits
650	0	4	_aStreptodornase and Streptokinase _xtherapeutic use
650	0	4	_aThrombophlebitis _xprevention & control
650	0	4	_aThrombosis _xprevention & control
650	0	4	_aVasodilator Agents _xtherapeutic use
650	0	4	_aVenoms _xtherapeutic use
773	0		_tThe American journal of cardiology _gvol. 27 _gno. 6 _gp. 659-69
856	4	0	_uhttps://doi.org/10.1016/0002-9149(71)90232-3 _zAvailable from publisher's website
999			_c4402034 _d4402034